HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

International Conference on Advanced Pulmonology, Respiratory Medicine & Lung Health

June 25-27, 2026 | Barcelona, Spain

June 25 -27, 2026 | Barcelona, Spain

Pneumothorax treatment

Pneumothorax treatment

Pneumothorax occurs when air enters the pleural space, causing partial or complete lung collapse. Etiologies include spontaneous rupture of alveoli, trauma, or complications from medical procedures. Symptoms vary depending on severity and may range from mild chest discomfort and shortness of breath to sudden respiratory distress and hypotension. Prompt recognition is critical, as untreated cases can progress rapidly and become life-threatening. Diagnosis relies on chest imaging, including X-ray or computed tomography, to confirm the presence and size of the pneumothorax and assess underlying lung pathology.

Treatment strategies depend on the size, cause, and clinical stability of the patient. Small, asymptomatic pneumothoraces may resolve with observation and supplemental oxygen, while larger or symptomatic cases often require needle aspiration or chest tube insertion to evacuate air and allow lung re-expansion. Recurrent or persistent pneumothoraces may necessitate surgical intervention such as video-assisted thoracoscopic surgery (VATS) with pleurodesis. Post-treatment care emphasizes monitoring for recurrence, pulmonary rehabilitation, and patient education on lifestyle modifications, including avoiding high-pressure environments and smoking cessation. Advances in minimally invasive techniques and evidence-based management protocols have improved recovery rates and minimized complications, making pneumothorax treatment safer and more effective for a broad range of patients.

Submit your abstract Today

Watsapp